(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 35.27%60.98M | 308.35%57.08M | 808.24%46.5M | 55.43%101.35M | 262.08%37.18M | 248.21%45.08M | 15.52%13.98M | -82.87%5.12M | -50.21%65.21M | -78.68%10.27M |
Net income from continuing operations | 1,300.71%39M | 681.07%29.14M | 3,203.77%10.71M | 57.93%-6.19M | 168.61%2.42M | 16.70%-3.25M | 65.01%-5.01M | -104.89%-345K | -111.20%-14.71M | -114.24%-3.53M |
Operating gains losses | -100.72%-3K | -106.86%-12K | -104.54%-26K | -52.30%1.38M | -31.49%211K | -72.55%418K | -63.00%175K | -1.72%573K | 108.53%2.89M | -20.00%308K |
Depreciation and amortization | 1.28%24.3M | -20.08%22.55M | 27.48%24.38M | 113.61%95.19M | 77.70%23.86M | 109.24%23.99M | 149.34%28.22M | 128.93%19.13M | 58.78%44.56M | 65.35%13.43M |
Asset impairment expenditure | --0 | --0 | --0 | -69.49%3.6M | --0 | --900K | --0 | --2.7M | 123.11%11.8M | --0 |
Remuneration paid in stock | -3.66%316K | -13.73%1.34M | -54.57%806K | 23.62%4.09M | -48.72%440K | -60.15%328K | -0.19%1.55M | 2,234.21%1.77M | 27.15%3.31M | 60.98%858K |
Other non cashItems | 124.48%757K | 105.96%166K | -43.02%1.67M | -55.69%7.09M | 2.61%10.03M | -160.71%-3.09M | -228.35%-2.78M | -44.03%2.94M | -63.52%16.01M | 67.91%9.78M |
Change In working capital | 67.44%22.23M | 246.42%11.96M | 150.95%9.48M | -171.31%-13.5M | --0 | 90.24%13.28M | -275.98%-8.17M | -230.43%-18.6M | -11.56%18.93M | -159.32%-6.96M |
-Change in receivables | -93.18%427K | 114.11%339K | 182.20%910K | -78.03%228K | -4.08%-2.53M | 415.78%6.27M | -145.53%-2.4M | -743.60%-1.11M | 124.87%1.04M | 20.63%-2.43M |
-Change in inventory | -4.47%-1.01M | -181.77%-3.55M | 105.28%385K | -39.52%-3.28M | 168.07%631K | -136.61%-962K | 321.86%4.34M | -248.38%-7.3M | 51.13%-2.35M | -1,595.16%-927K |
-Change in payables and accrued expense | 186.08%22.81M | 250.09%15.17M | 180.21%8.18M | -151.60%-10.45M | 152.65%1.9M | 25.86%7.97M | -864.75%-10.11M | -163.03%-10.2M | -33.39%20.24M | -124.46%-3.6M |
Tax refund paid | -304.80%-25.62M | -161,200.00%-8.06M | 82.95%-518K | 155.07%9.68M | 105.80%210K | 553.52%12.51M | 100.09%5K | 46.51%-3.04M | -54.72%-17.58M | -13.54%-3.62M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 35.27%60.98M | 308.35%57.08M | 808.24%46.5M | 55.43%101.35M | 262.09%37.18M | 248.21%45.08M | 15.52%13.98M | -82.87%5.12M | -50.21%65.21M | -78.68%10.27M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 10.80%-29.61M | -48.69%-25.31M | -28.43%-29.45M | 32.58%-98.59M | 34.98%-25.44M | 1.45%-33.19M | 56.14%-17.02M | 33.73%-22.93M | -10.34%-146.22M | 33.83%-39.13M |
Net PPE purchase and sale | 6.72%-29.52M | -47.04%-25.03M | -13.81%-26.1M | 31.23%-100.2M | 26.92%-28.6M | 5.96%-31.65M | 55.57%-17.02M | 33.73%-22.93M | -1.61%-145.7M | 18.19%-39.13M |
Net business purchase and sale | --0 | ---280K | ---3.35M | --3.16M | --3.16M | --0 | --0 | --0 | --0 | ---- |
Net other investing changes | 94.42%-86K | ---- | ---- | -197.11%-1.54M | --0 | -6,068.00%-1.54M | ---- | ---- | -142.47%-519K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 10.80%-29.61M | -48.69%-25.31M | -28.43%-29.45M | 32.58%-98.59M | 34.98%-25.44M | 1.45%-33.19M | 56.14%-17.02M | 33.73%-22.93M | -10.34%-146.22M | 33.83%-39.13M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 118.95%449K | -59,957.14%-29.33M | -204.96%-10.17M | -90.56%5.42M | -105.22%-1.95M | -110.79%-2.37M | 102.18%49K | 2,217.70%9.69M | 1,213.08%57.44M | 2,251.50%37.31M |
Net issuance payments of debt | 49.63%-615K | -215.47%-29.57M | -11.22%-10.83M | -146.51%-21.14M | -103.10%-809K | -105.17%-1.22M | -326.24%-9.37M | -366.87%-9.74M | 617.83%45.46M | 845.84%26.11M |
Net common stock issuance | --0 | --0 | --0 | 144.56%31.99M | --0 | --0 | --11M | --20.99M | --13.08M | --13.08M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --1.4M | --1.06M | 151.33%1.7M | -75.06%756K | --80K | --0 | --0 | -75.57%676K | -41.19%3.03M | --0 |
Interest paid (cash flow from financing activities) | 69.84%-336K | 30.21%-820K | 20.86%-1.04M | -96.73%-4.81M | 5.08%-1.21M | -89.46%-1.11M | -271.84%-1.18M | -397.72%-1.31M | -104.86%-2.45M | -277.29%-1.28M |
Net other financing activities | ---- | ---- | ---- | 18.75%-1.37M | 99.50%-3K | 96.76%-35K | ---401K | ---930K | -392.69%-1.69M | -20,100.00%-606K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 118.95%449K | -59,957.14%-29.33M | -204.96%-10.17M | -90.56%5.42M | -105.22%-1.95M | -110.79%-2.37M | 102.18%49K | 2,217.70%9.69M | 1,213.08%57.44M | 2,251.50%37.31M |
Net cash flow | ||||||||||
Beginning cash position | 129.74%50.7M | 92.55%48.25M | 24.67%41.37M | -41.54%33.19M | 27.65%31.58M | -6.16%22.07M | -52.24%25.06M | -41.54%33.19M | -10.58%56.76M | -64.39%24.74M |
Current changes in cash | 234.40%31.82M | 181.69%2.45M | 184.69%6.88M | 134.72%8.19M | 15.93%9.79M | 676.73%9.52M | 89.66%-2.99M | -89.31%-8.13M | -251.09%-23.58M | 166.44%8.44M |
End cash Position | 161.27%82.52M | 129.74%50.7M | 92.55%48.25M | 24.67%41.37M | 24.67%41.37M | 27.65%31.58M | -6.16%22.07M | -52.24%25.06M | -41.54%33.19M | -41.54%33.19M |
Free cash from | 134.35%31.45M | 854.48%29.19M | 214.28%20.36M | 100.40%319K | 129.66%8.58M | 164.24%13.42M | 85.25%-3.87M | -278.20%-17.81M | -545.38%-80.76M | -8,864.55%-28.92M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data